A consultation is required to assess candidacy and determine the appropriate protocol
[] Despite the benefits of using DFO to treat a variety of human diseases, essentially iron overload-associated pathologies, administration of this siderophore can result in certain adverse effects, which encompass failure of human development, bone dysplasia, retinal pigment epithelium modification, visual impairment, decreased night vision as well as impairments to the cardiovascular, respiratory, gastrointestinal, renal, cutaneous and neurological systems
At 20 mg/kg, we observed a 4-fold increase with ~13% gametocytemia
BPC-157 regulates NO production bidirectionallycountering both excess and deficiency based on what tissue needs
5,6 DMF/MMF has no clinically significant drugdrug interactions with cytochrome p450 (CYP) enzymes or the P-glycoprotein drug transporter
doi: 10.1038/302703a0